2025

Targeting TROP2 in aggressive variant and neuroendocrine prostate cancer.
Amsberg G, Kaune M, Bergmann L, Busenbender T, Strewinsky N, Paulsen F, Dum D, Tilki D, Graefen M, Bokemeyer C, Werner S, Dyshlovoy S
J CLIN ONCOL. 2025;43:171-171.

Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the GMALL B-ALL/NHL 2002 Protocol: A Tertiary Center Experience
Kosch R, Schaefers C, Frenzel C, Fiedler W, Weisel K, Bokemeyer C, Seidel C, Paulsen F
CL LYMPH MYELOM LEUK. 2025;25(7):e533-e540.e2.

2024

Diagnosing intravascular B-cell lymphoma using nanopore sequencing of cell-free DNA from cerebrospinal fluid
Schmidt B, Afflerbach A, Ludewig P, Dirksen P, Paulsen F, Magnus T, Alawi M, Schüller U, Weisel K, Bokemeyer C, Christopeit M
ESMO OPEN. 2024;9(11):103974.

Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serum
Seidel C, Paulsen F, Nestler T, Cathomas R, Hentrich M, Paffenholz P, Bokemeyer C, Heidenreich A, Nettersheim D, Bremmer F
VIRCHOWS ARCH. 2024;485(1):123-130.

2023

Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors
Kirchner K, Seidel C, Paulsen F, Sievers B, Bokemeyer C, Lessel D
J CLIN MED. 2023;12(22):.

Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis
Schaefers C, Paulsen F, Frenzel C, Weisel K, Bokemeyer C, Seidel C
BRIT J HAEMATOL. 2023;201(2):222-226.

2022

CDK7 is a prognostic biomarker for non-small cell lung cancer
Kuempers C, Jagomast T, Heidel C, Paulsen F, Bohnet S, Schierholz S, Dreyer E, Kirfel J, Perner S
FRONT ONCOL. 2022;12:.

Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients
Madanchi R, Engel N, Alsdorf W, Oing C, Frenzel C, Paulsen F, Bokemeyer C, Seidel C
BONE MARROW TRANSPL. 2022;57(5):729-733.

Targeting Cyclin-Dependent Kinase 7 - Association between CDK7 and pMED1 Expression in Prostate Cancer Tissue
Paulsen F, Kang D, Becker F, Roth D, Jörg V, Dreyer E, Roesch M, Seidel C, Merseburger A, Kirfel J, Sailer V, Offermann A, Perner S
CARCINOGENESIS. 2022;43(8):779-786.

Editorial Comment to Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors
Paulsen F, Seidel C
INT J UROL. 2022;29(7):747.

2021

Delta-Like Protein 3 Expression in Paired Chemonaive and Chemorelapsed Small Cell Lung Cancer Samples
Kuempers C, Jagomast T, Krupar R, Paulsen F, Heidel C, Ribbat-Idel J, Idel C, Märkl B, Anlauf M, Berezowska S, Tiemann M, Bösmüller H, Fend F, Kalsdorf B, Bohnet S, Dreyer E, Sailer V, Kirfel J, Perner S
FRONT MED-LAUSANNE. 2021;8:.

Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19)
Paulsen F, Schaefers C, Langer F, Frenzel C, Wenzel U, Hengel F, Bokemeyer C, Seidel C
BLOOD. 2021;138(11):996-999.

Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
Ribbat-Idel J, Dressler F, Krupar R, Watermann C, Paulsen F, Kuppler P, Klapper L, Offermann A, Wollenberg B, Rades D, Laban S, Reischl M, Bruchhage K, Idel C, Perner S
FRONT MED-LAUSANNE. 2021;8:640515.

Immunologic "Cold" Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
Ribbat-Idel J, Perner S, Kuppler P, Klapper L, Krupar R, Watermann C, Paulsen F, Offermann A, Bruchhage K, Wollenberg B, Idel C
FRONT MED-LAUSANNE. 2021.

2020

NR2F6 as a Prognostic Biomarker in HNSCC
Klapper L, Ribbat-Idel J, Kuppler P, Paulsen F, Bruchhage K, Rades D, Offermann A, Kirfel J, Wollenberg B, Idel C, Perner S
INT J MOL SCI. 2020;21(15):.

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
Paulsen F, Idel C, Ribbat-Idel J, Kuppler P, Klapper L, Rades D, Bruchhage K, Wollenberg B, Brägelmann J, Perner S, Offermann A
INT J MOL SCI. 2020;21(15):.

Letzte Aktualisierung aus dem FIS: 15.09.2025 - 00:38 Uhr